HIGH CEREBROSPINAL-FLUID AND SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA IN ASYMPTOMATIC HIV-1 SEROPOSITIVE INDIVIDUALS - CORRELATION WITH INTERLEUKIN-2 AND SOLUBLE IL-2 RECEPTOR

被引:17
作者
CIARDI, M
SHARIEF, MK
THOMPSON, EJ
SALOTTI, A
VULLO, V
SORICE, F
CIRELLI, A
机构
[1] UCL NATL HOSP NEUROL & NEUROSURG, INST NEUROL, LONDON WC1N 3BG, ENGLAND
[2] UNIV ROMA LA SAPIENZA, INST INFECT DIS, ROME, ITALY
[3] UNIV PISA, DEPT INFECT DIS, PISA, ITALY
关键词
HIV-1; AIDS; CEREBROSPINAL FLUID; TUMOR NECROSIS FACTOR; INTERLEUKIN-2; SOLUBLE IL-2 RECEPTOR;
D O I
10.1016/0022-510X(94)90031-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The relationship between tumour necrosis factor-alpha (TNF-alpha) and the interleukin-2 (ILL-2) system in HIV-1 infection is important in understanding the dynamics of early immune response before the development of acquired immunodeficiency syndrome. Levels of TNF-alpha, IL-2 and soluble IL-2 receptor (sIL-2R) in serum and cerebrospinal fluid (CSF) samples from 31 asymptomatic HIV-1 seropositive individuals were measured. High levels of TNF-alpha were detected in CSF of 17 (55%) and serum of 22 (71%) subjects, 15 (88%) of whom had elevated CSF IL-2 levels and 16 (94%) had high sIL-2R levels. Moreover, CSF levels of TNF-alpha significantly correlated with CSF levels of IL-2 and sIL-2R. TNF-alpha, IL-2 and sIL-2R seem to be released within the intrathecal compartment early in the course of HIV-1 infection. In view of the known cytotoxic effects of TNF-alpha, an early release may contribute to subsequent development of neurological complications.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 29 条
[1]   BRAIN PATHOLOGY INDUCED BY INFECTION WITH THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) - A HISTOLOGICAL, IMMUNOCYTOCHEMICAL, AND ELECTRON MICROSCOPICAL STUDY OF 100 AUTOPSY CASES [J].
BUDKA, H ;
COSTANZI, G ;
CRISTINA, S ;
LECHI, A ;
PARRAVICINI, C ;
TRABATTONI, R ;
VAGO, L .
ACTA NEUROPATHOLOGICA, 1987, 75 (02) :185-198
[2]   INTRATHECAL SYNTHESIS OF INTERLEUKIN-2 AND SOLUBLE IL-2 RECEPTOR IN ASYMPTOMATIC HIV-1 SEROPOSITIVE INDIVIDUALS - CORRELATION WITH LOCAL PRODUCTION OF SPECIFIC IGM AND IGG ANTIBODIES [J].
CIARDI, M ;
SHARIEF, MK ;
NOORI, MA ;
THOMPSON, EJ ;
SALOTTI, A ;
ROSSI, F ;
VULLO, V ;
CATANIA, S ;
SORICE, F ;
CIRELLI, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1993, 115 (01) :117-122
[3]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[4]   SUBACUTE ENCEPHALOMYELITIS OF AIDS AND ITS RELATION TO HTLV-III INFECTION [J].
DELAMONTE, SM ;
HO, DD ;
SCHOOLEY, RT ;
RICHARDSON, EP ;
HIRSCH, MS .
NEUROLOGY, 1987, 37 (04) :562-569
[5]  
FOLI A, 1993, J ACQ IMMUN DEF SYND, V6, P736
[6]   THE NEUROPATHOLOGY OF THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) - A REVIEW [J].
GRAY, F ;
GHERARDI, R ;
SCARAVILLI, F .
BRAIN, 1988, 111 :245-266
[7]   SOLUBLE INTERLEUKIN-2 RECEPTOR AND SOLUBLE CD8 IN SERUM AND CEREBROSPINAL-FLUID DURING HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEUROLOGIC DISEASE [J].
GRIFFIN, DE ;
MCARTHUR, JC ;
CORNBLATH, DR .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 28 (02) :97-109
[8]   ELEVATED ALPHA-TUMOR-NECROSIS-FACTOR LEVELS IN SPINAL-FLUID FROM HIV-1-INFECTED PATIENTS WITH CENTRAL-NERVOUS-SYSTEM INVOLVEMENT [J].
GRIMALDI, LME ;
MARTINO, GV ;
FRANCIOTTA, DM ;
BRUSTIA, R ;
CASTAGNA, A ;
PRISTERA, R ;
LAZZARIN, A .
ANNALS OF NEUROLOGY, 1991, 29 (01) :21-25
[9]   ISOLATION OF HTLV-III FROM CEREBROSPINAL-FLUID AND NEURAL TISSUES OF PATIENTS WITH NEUROLOGIC SYNDROMES RELATED TO THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
HO, DD ;
ROTA, TR ;
SCHOOLEY, RT ;
KAPLAN, JC ;
ALLAN, JD ;
GROOPMAN, JE ;
RESNICK, L ;
FELSENSTEIN, D ;
ANDREWS, CA ;
HIRSCH, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (24) :1493-1497
[10]   PIVOTAL ROLE OF ENDOGENOUS TNF-ALPHA IN THE IL-2-DRIVEN ACTIVATION AND PROLIFERATION OF THE FUNCTIONALLY IMMATURE NK FREE SUBSET [J].
JEWETT, A ;
BONAVIDA, B .
CELLULAR IMMUNOLOGY, 1993, 151 (02) :257-269